A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis
Clinical trial NCT06837233 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06837233
- Sponsor
- Prime Gene Therapeutics Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-12
- Primary completion
- 2025-05-15
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.